par Metzger-Filho, Otto;Vora, Tushar Shailesh ;Awada, Ahmad
Référence Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39)
Publication Publié, 2010-04
Référence Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39)
Publication Publié, 2010-04
Article révisé par les pairs
Titre: |
|
Auteur: | Metzger-Filho, Otto; Vora, Tushar Shailesh; Awada, Ahmad |
Informations sur la publication: | Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39) |
Statut de publication: | Publié, 2010-04 |
Sujet CREF: | Cancérologie |
Mots-clés: | Adjuvant therapy |
Chemotherapy | |
Human epidermal growth factor receptor-2 (HER2) | |
Metastatic breast cancer | |
Trastuzumab | |
Tyrosine kinase inhibitors | |
MeSH keywords: | Antibodies, Monoclonal -- administration & dosage |
Antibodies, Monoclonal, Humanized | |
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use | |
Breast Neoplasms -- drug therapy -- pathology | |
Chemotherapy, Adjuvant -- methods | |
Disease Progression | |
Drug Delivery Systems | |
Drug Resistance, Neoplasm | |
Female | |
Humans | |
Neoplasm Metastasis | |
Receptor, erbB-2 -- antagonists & inhibitors -- metabolism | |
Signal Transduction -- drug effects | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
SCOPUS: cp.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1354-3784 |
info:doi/10.1517/13543781003730135 | |
info:scp/77950682786 | |
info:pmid/20374028 |